Tricuspid stenosis classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (3 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Tricuspid stenosis}} | {{Tricuspid stenosis}} | ||
{{CMG}} ; {{AE}} {{ADG}} | {{CMG}} ; {{AE}} [[User:Mohammed Salih|Mohammed Salih, M.D.]] {{sali}} {{ADG}} | ||
==Overview== | ==Overview== | ||
[[Tricuspid stenosis]] (TS) staging sections into categories A, B, C, D. Stages C (without symptoms) and D (with symptoms). When [[valve]] and/or chordal thickening and [[calcification]] are evident, there are additional findings indicative of severe TS, for example, pressure gradient greater than or equal to 5 mm Hg, pressure half-time greater than or equal to 190 milliseconds, [[valve]] area less than or equal to 1.0 cm^2, associated moderate right atrial enlargement, and [[inferior vena cava]] dilatation. | [[Tricuspid stenosis]] (TS) staging sections into categories A, B, C, D. Stages C (without symptoms) and D (with symptoms). When [[valve]] and/or chordal thickening and [[calcification]] are evident, there are additional findings indicative of severe TS, for example, pressure gradient greater than or equal to 5 mm Hg, pressure half-time greater than or equal to 190 milliseconds, [[valve]] area less than or equal to 1.0 cm^2, associated moderate right atrial enlargement, and [[inferior vena cava]] dilatation. | ||
==Classification== | ==Classification== | ||
[[Tricuspid stenosis]] (TS) is staged based on the [[valve]] [[anatomy]] and [[hemodynamics]], and the [[Hemodynamics|hemodynamic]] consequences. No criteria for Stage A or B were included in the 2014 [[American Heart Association]]/American College of Cardiology [[valve]] guidelines. Stage C is defined as severe TS without symptoms. Stage D is defined as severe TS with symptoms.<ref name="pmid24603191">{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA | display-authors=etal| title=2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=J Am Coll Cardiol | year= 2014 | volume= 63 | issue= 22 | pages= e57-185 | pmid=24603191 | doi=10.1016/j.jacc.2014.02.536 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24603191 }}</ref> | [[Tricuspid stenosis]] (TS) is staged based on the [[valve]] [[anatomy]] and [[hemodynamics]], and the [[Hemodynamics|hemodynamic]] consequences. No criteria for Stage A or B were included in the 2014 [[American Heart Association]]/American College of Cardiology [[valve]] guidelines. Stage C is defined as severe TS without symptoms. Stage D is defined as severe TS with symptoms.<ref name="pmid24603191">{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA | display-authors=etal| title=2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=J Am Coll Cardiol | year= 2014 | volume= 63 | issue= 22 | pages= e57-185 | pmid=24603191 | doi=10.1016/j.jacc.2014.02.536 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24603191 }}</ref><ref name="BaumgartnerHung2009">{{cite journal|last1=Baumgartner|first1=Helmut|last2=Hung|first2=Judy|last3=Bermejo|first3=Javier|last4=Chambers|first4=John B.|last5=Evangelista|first5=Arturo|last6=Griffin|first6=Brian P.|last7=Iung|first7=Bernard|last8=Otto|first8=Catherine M.|last9=Pellikka|first9=Patricia A.|last10=Quiñones|first10=Miguel|title=Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice|journal=Journal of the American Society of Echocardiography|volume=22|issue=1|year=2009|pages=1–23|issn=08947317|doi=10.1016/j.echo.2008.11.029}}</ref> | ||
{| class="wikitable" | {| class="wikitable" | ||
!Stage | !Stage | ||
| Line 24: | Line 24: | ||
| | | | ||
*Stage C-No symptoms | *Stage C-No symptoms | ||
*Stage D-Symptoms variable and dependent on the severity of associated valve disease and degree of obstruction | *Stage D-Symptoms variable and dependent on the severity of associated [[valve]] disease and degree of obstruction | ||
|} | |} | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category: Cardiology]] | |||
Latest revision as of 21:28, 1 April 2020
|
Tricuspid stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tricuspid stenosis classification On the Web |
|
American Roentgen Ray Society Images of Tricuspid stenosis classification |
|
Risk calculators and risk factors for Tricuspid stenosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Mohammed Salih, M.D. Syed Musadiq Ali M.B.B.S.[2] Aditya Ganti M.B.B.S. [3]
Overview
Tricuspid stenosis (TS) staging sections into categories A, B, C, D. Stages C (without symptoms) and D (with symptoms). When valve and/or chordal thickening and calcification are evident, there are additional findings indicative of severe TS, for example, pressure gradient greater than or equal to 5 mm Hg, pressure half-time greater than or equal to 190 milliseconds, valve area less than or equal to 1.0 cm^2, associated moderate right atrial enlargement, and inferior vena cava dilatation.
Classification
Tricuspid stenosis (TS) is staged based on the valve anatomy and hemodynamics, and the hemodynamic consequences. No criteria for Stage A or B were included in the 2014 American Heart Association/American College of Cardiology valve guidelines. Stage C is defined as severe TS without symptoms. Stage D is defined as severe TS with symptoms.[1][2]
| Stage | Definition | Valve anatomy | Valve hemodynamics | Hemodynamic consequences | Symptoms |
|---|---|---|---|---|---|
| C, D | Severe TS | Thickened, distorted, calcified leaflets |
|
Right atrial / Inferior vena cava enlargement |
|
References
- ↑ Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". J Am Coll Cardiol. 63 (22): e57–185. doi:10.1016/j.jacc.2014.02.536. PMID 24603191.
- ↑ Baumgartner, Helmut; Hung, Judy; Bermejo, Javier; Chambers, John B.; Evangelista, Arturo; Griffin, Brian P.; Iung, Bernard; Otto, Catherine M.; Pellikka, Patricia A.; Quiñones, Miguel (2009). "Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice". Journal of the American Society of Echocardiography. 22 (1): 1–23. doi:10.1016/j.echo.2008.11.029. ISSN 0894-7317.